IL18 and metabolic syndrome: In line with these results, we showed that IL-18 was a strong and independent predictor of cardiovascular events in elderly men with the metabolic syndrome, also after adjustment for CRP and IL-6, and with a synergistic effect of IL-18 and fasting glucose in the cardiovascular risk prediction [63].